Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Oxaloacetate in Amyotrophic Lateral Sclerosis

NCT04204889 is registered in ClinicalTrials.gov with Omar Jawdat as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04204889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Oxaloacetate in Amyotrophic Lateral Sclerosis
Lead sponsor
Omar Jawdat
Phase
Phase 1
Overall status
Completed
Start date
March 17, 2020
Completion date
August 2, 2023
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als